Nav: Home

Could a cancer drug be repurposed for fragile X syndrome?

April 27, 2016

An experimental cancer drug can improve learning and memory in mice with fragile X syndrome, according to a new study. Unlike other potential treatments for this disorder that target neurons, the cancer drug coaxes neural stem cells to generate neurons potentially critical to cognitive function. The findings offer new hope to patients with fragile X syndrome, the most common cause of inherited intellectual disability and autism spectrum disorder, which currently lacks an effective treatment. Mutations in the fragile X mental retardation (FMR1) gene lead to loss of FMRP, a protein that regulates the expression of many genes in neurons. FMRP deficiency is known to impair neural stem cells' ability to generate new neurons in the adult brain, but how this occurs is not fully understood. Studying a mouse model of fragile X syndrome, Yue Li and colleagues found that loss of FMRP led to greater activation of neural stem cells, enhancing their differentiation into astrocytes, but not neurons. The researchers identified the enzyme MDM2 as a key target of FMRP in neural stem cells. FMRP deficiency led to greater MDM2 activity, resulting in enhanced neural stem cell proliferation but reduced differentiation. A specific MDM2 inhibitor known as Nutlin, currently in an early clinical trial for retinoblastoma, seemed to correct this imbalance between neural stem cell proliferation and differentiation. Low doses of Nutlin restored spatial memory and learning in FMRP-deficient mice, opening the door to repurposing the drug as a potential treatment for fragile X syndrome.

American Association for the Advancement of Science

Related Neurons Articles:

New tool to identify and control neurons
One of the big challenges in the Neuroscience field is to understand how connections and communications trigger our behavior.
Neurons that regenerate, neurons that die
In a new study published in Neuron, investigators report on a transcription factor that they have found that can help certain neurons regenerate, while simultaneously killing others.
How neurons use crowdsourcing to make decisions
When many individual neurons collect data, how do they reach a unanimous decision?
Neurons can learn temporal patterns
Individual neurons can learn not only single responses to a particular signal, but also a series of reactions at precisely timed intervals.
A turbo engine for tracing neurons
Putting a turbo engine into an old car gives it an entirely new life -- suddenly it can go further, faster.
Brain neurons help keep track of time
Turning the theory of how the human brain perceives time on its head, a novel analysis in mice reveals that dopamine neuron activity plays a key role in judgment of time, slowing down the internal clock.
During infancy, neurons are still finding their places
Researchers have identified a large population of previously unrecognized young neurons that migrate in the human brain during the first few months of life, contributing to the expansion of the frontal lobe, a region important for social behavior and executive function.
How many types of neurons are there in the brain?
For decades, scientists have struggled to develop a comprehensive census of cell types in the brain.
Molecular body guards for neurons
In the brain, patterns of neural activity are perfectly balanced.
Engineering researchers use laser to 'weld' neurons
University of Alberta researchers have developed a method of connecting neurons, using ultrashort laser pulses -- a breakthrough technique that opens the door to new medical research and treatment opportunities.

Related Neurons Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...